An open, noncomparative study of doxazosin in essential hypertension: Experience in general practice in the Netherlands

This publication has 10 references indexed in Scilit:

• Stratifying the patient at risk from coronary disease: New insights from the framingham heart study
  American Heart Journal, 1990
• Clinical experience with doxazosin in general medical practice
  American Heart Journal, 1988
• Effects of antihypertensives on plasma lipids and lipoprotein metabolism
  American Heart Journal, 1988
• The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized controlled trials
  Progress in Cardiovascular Diseases, 1986
• Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.
  British Journal of Clinical Pharmacology, 1986
• The alpha 1‐adrenoceptor antagonist profile of doxazosin: preclinical pharmacology.
  British Journal of Clinical Pharmacology, 1986
• A population at risk: Prevalence of high cholesterol levels in hypertensive patients in the framingham study
  The American Journal of Medicine, 1986
• Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)
  Journal Of Hypertension, 1985
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.
  BMJ, 1985
• Multiple Risk Factor Intervention Trial
  JAMA, 1982